414 POSTER A phase I, open-label, dose escalation study of the humanized monoclonal antibody (HuMAb) TRC093, an inhibitor of angiogenesis that binds to cleaved collagen, in patients with locally advanced or metastatic solid tumors

✍ Scribed by M.S. Gordon; L.S. Rosen; F. Robert; D.S. Mendelson; D. Kleinzweig; B.J. Adams; C.P. Theuer

• Book ID: 119599570
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 61 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)72348-6